Theravance Biopharma Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MADISON AVENUE PARTNERS, LP | 08/14/2026 | 9.21 M | $156.61 M | -3.14% | 17.83% |
| WEISS ASSET MANAGEMENT LP | 08/14/2026 | 7.46 M | $126.77 M | 0.00% | 14.43% |
| BLACKROCK, INC. | 08/07/2026 | 4.56 M | $77.56 M | 6.20% | 8.83% |
| NEWTYN MANAGEMENT, LLC | 08/14/2026 | 3.43 M | $58.38 M | -29.07% | 6.65% |
| IRENIC CAPITAL MANAGEMENT LP | 08/14/2026 | 2.76 M | $46.94 M | 0.00% | 5.34% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 1.77 M | $30.12 M | -0.69% | 3.43% |
| STATE STREET CORP | 08/07/2026 | 1.33 M | $22.59 M | 2.41% | 2.57% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 1.23 M | $20.83 M | -2.62% | 2.37% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 1.19 M | $20.15 M | 24.25% | 2.29% |
| ACADIAN ASSET MANAGEMENT LLC | 08/13/2026 | 1.17 M | $19.96 M | -7.96% | 2.27% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 1.12 M | $19.01 M | -1.72% | 2.16% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 1.04 M | $17.73 M | 6.04% | 2.02% |
| MACKENZIE FINANCIAL CORP | 08/13/2026 | 985.85 K | $16.76 M | 296.43% | 1.91% |
| MORGAN STANLEY | 08/13/2026 | 705.20 K | $11.99 M | 38.20% | 1.36% |
| OASIS MANAGEMENT CO LTD. | 08/14/2026 | 583.49 K | $9.92 M | 0.00% | 1.13% |
| CITADEL ADVISORS LLC | 09/02/2026 | 506.67 K | $8.61 M | 488.53% | 0.98% |
| UBS GROUP AG | 08/13/2026 | 488.31 K | $8.30 M | -36.09% | 0.95% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 429.81 K | $7.31 M | 48.48% | 0.83% |
| NORTHERN TRUST CORP | 08/13/2026 | 404.36 K | $6.87 M | 9.13% | 0.78% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 394.16 K | $6.70 M | -1.65% | 0.76% |
| JUPITER TOPCO LLC | 08/14/2026 | 387.49 K | $6.59 M | 100.00% | 0.75% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 339.96 K | $5.78 M | -18.31% | 0.66% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 321.15 K | $5.46 M | 3.40% | 0.62% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 321.15 K | $5.46 M | 100.00% | 0.62% |
| GLAZER CAPITAL, LLC | 08/17/2026 | 301.83 K | $5.13 M | 100.00% | 0.58% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 272.23 K | $4.63 M | 3.88% | 0.53% |
| JPMORGAN CHASE & CO | 08/12/2026 | 221.85 K | $3.78 M | 74.32% | 0.43% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 08/14/2026 | 208.78 K | $3.55 M | 0.00% | 0.40% |
| MARSHALL WACE, LLP | 08/13/2026 | 188.75 K | $3.21 M | 18.78% | 0.37% |
| HRT FINANCIAL LP | 08/14/2026 | 180.64 K | $3.07 M | -45.04% | 0.35% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 08/13/2026 | 179.64 K | $3.05 M | -28.07% | 0.35% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 08/13/2026 | 179.19 K | $3.05 M | -10.22% | 0.35% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 154.32 K | $2.62 M | 20.64% | 0.30% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 138.61 K | $2.36 M | -35.72% | 0.27% |
| CWA ASSET MANAGEMENT GROUP, LLC | 07/14/2026 | 134.99 K | $2.29 M | 42.25% | 0.26% |
| FMR LLC | 08/13/2026 | 133.87 K | $2.28 M | 8.86% | 0.26% |
| NUVEEN, LLC | 08/11/2026 | 133.06 K | $2.26 M | 4.22% | 0.26% |
| WEDGE CAPITAL MANAGEMENT L L P/NC | 07/10/2026 | 128.85 K | $2.19 M | 100.00% | 0.25% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 120.78 K | $2.05 M | 5.88% | 0.23% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 115.40 K | $1.96 M | 100.00% | 0.22% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 113.48 K | $1.93 M | 3.45% | 0.22% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2026 | 108.88 K | $1.85 M | 100.00% | 0.21% |
| MARTINGALE ASSET MANAGEMENT L P | 08/13/2026 | 105.50 K | $1.79 M | 60.03% | 0.20% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 103.26 K | $1.76 M | 6.29% | 0.20% |
| AMERICAN CENTURY COMPANIES INC | 08/12/2026 | 102.28 K | $1.74 M | -13.13% | 0.20% |
| ENGINEERS GATE MANAGER LP | 08/14/2026 | 100.14 K | $1.70 M | -11.56% | 0.19% |
| RANGELEY CAPITAL, LLC | 08/14/2026 | 99.50 K | $1.69 M | -3.40% | 0.19% |
| JACKSON CREEK INVESTMENT ADVISORS LLC | 08/10/2026 | 85.51 K | $1.44 M | -27.88% | 0.17% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 85.26 K | $1.45 M | 13.47% | 0.17% |
| SWISS NATIONAL BANK | 08/11/2026 | 77.50 K | $1.32 M | 3.20% | 0.15% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Theravance Biopharma Inc institutional Ownership - FAQ's
During the previous two years, 266 institutional investors and hedge funds held shares of Theravance Biopharma Inc. The most heavily invested institutionals were:
Madison Avenue Partners, LP: 9.21 M
Weiss Asset Management LP: 7.46 M
BlackRock, Inc.: 4.56 M
Newtyn Management, LLC: 3.43 M
Irenic Capital Management LP: 2.76 M
VANGUARD CAPITAL MANAGEMENT LLC: 1.77 M
93.71% of Theravance Biopharma Inc stock is owned by institutional investors.
Institutional investors have bought a total of 79.59 M shares in the last 24 months. This purchase volume represents approximately $1.11 B in transactions.